Covestor LTD Innoviva, Inc. Transaction History

Covestor LTD

$181 Million
Q3 2025

A detailed history of Covestor LTD transactions in Innoviva, Inc. stock. As of the latest transaction made, Covestor LTD holds 496 shares of INVA stock, worth $11,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares

496

Previous 554 10.47%

Holding current value

$11,036

Previous $11,000 18.18%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$18.17 - $20.92 $1,053 - $1,213	-58 Reduced 10.47%	496 $9,000
Q2 2025 Aug 11, 2025	SELL	$17.1 - $21.8 $1,812 - $2,310	-106 Reduced 16.06%	554 $11,000
Q1 2025 May 12, 2025	BUY	$17.21 - $18.98 $395 - $436	23 Added 3.61%	660 $12,000
Q4 2024 Feb 13, 2025	SELL	$17.35 - $20.32 $694 - $812	-40 Reduced 5.91%	637 $11,000
Q3 2024 Nov 01, 2024	SELL	$16.33 - $20.04 $2,841 - $3,486	-174 Reduced 20.45%	677 $13,000

Q2 2024 Aug 09, 2024	BUY	$14.4 - $16.4 $547 - $623	38 Added 4.67%	851 $14,000
Q1 2024 May 10, 2024	BUY	$14.56 - $16.78 $422 - $486	29 Added 3.7%	813 $12,000
Q4 2023 Feb 09, 2024	BUY	$12.32 - $16.27 $9,252 - $12,218	751 Added 2275.76%	784 $12,000
Q3 2023 Nov 13, 2023	SELL	$12.37 - $13.89 $395 - $444	-32 Reduced 49.23%	33 $0
Q2 2023 Aug 11, 2023	SELL	$11.39 - $13.72 $4,715 - $5,680	-414 Reduced 86.43%	65 $1,000
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $1,223 - $1,550	114 Added 31.23%	479 $5,000
Q4 2022 Feb 13, 2023	SELL	$11.8 - $13.78 $271 - $316	-23 Reduced 5.93%	365 $4,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $1,091 - $1,430	94 Added 31.97%	388 $5,000
Q2 2022 Aug 10, 2022	SELL	$14.32 - $19.88 $2,348 - $3,260	-164 Reduced 35.81%	294 $4,000
Q1 2022 May 13, 2022	BUY	$15.39 - $20.25 $1,816 - $2,389	118 Added 34.71%	458 $9,000
Q4 2021 Feb 10, 2022	BUY	$15.91 - $18.72 $5,409 - $6,364	340 New	340 $6,000

Others Institutions Holding INVA

# of Institutions

281

Shares Held

82.7M

Call Options Held

13.2K

Put Options Held

156K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.55B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account